LncRNA在部分肿瘤中的差异表达及与mRNA结合作用关系的研究现状
Research Status of LncRNA Differential Expression and mRNA Binding in Some Tumors
DOI: 10.12677/ACM.2023.13102356, PDF,    科研立项经费支持
作者: 刘 震:青海大学研究生院,青海 西宁;朱海宏*:青海省人民医院普通外科,青海 西宁
关键词: LncRNAmRNAmiRNALncRNA与mRNA共表达网络LncRNA mRNA miRNA LncRNA and mRNA Co-Expression Network
摘要: 肿瘤是机体细胞在各种促进、抑制及其他各种因素的直接或间接的作用下形成的异于正常组织的增生与分化的新生物,在病因及其他致病因素被消除后其生长、侵袭等过程不会停滞,人类在健康的问题上对于恶性肿瘤对其产生的不利影响已变得日益明显,是迄今为止人类死亡的主要原因之一,其生长、侵袭等过程在正常机体中不受调节,且会破坏机体正常的细胞,进而影响相应的组织和器官。目前肿瘤的诊断方法有很多,但大多恶性肿瘤的发现较晚且有部分肿瘤标志物敏感性较低,以往曾长期将肿瘤的病理学诊断作为肿瘤的最终诊断,但近来随着分子生物学和精准医学的发展,肿瘤在分子诊断方面已经越来越受到重视,且可能会逐渐成为肿瘤的新的诊断标准。目前已有大量研究表明,长链非编码RNA (LncRNA)在结直肠癌、肝癌、胃癌等多种恶性肿瘤中有均显著差异的表达,且与mRNA结合作用后对肿瘤的生长、增殖、侵袭、迁移等过程起调节作用。此外,LncRNA与其他肿瘤检测方法相结合可提高其诊断率。该文总结了LncRNA在部分肿瘤中的差异表达及与mRNA结合对其产生的相应调节,并展望其在临床应用中的前景。
Abstract: Tumor is a new organism that is different from the proliferation and differentiation of normal tissue formed by the body cells under the direct or indirect action of various promoting, inhibiting and other factors. Its growth and invasion processes will not stop after the elimination of the etiology and other pathogenic factors. The adverse effects of human health on malignant tumors have be-come increasingly obvious. It is one of the main causes of human death so far, its growth, invasion and other processes are not regulated in the normal body, and will destroy the normal cells of the body, and then affect the corresponding tissues and organs. At present, there are many diagnostic methods for tumor, but most malignant tumors are found late and some tumor markers have low sensitivity. In the past, pathological diagnosis of tumor was used as the final diagnosis of tumor for a long time, but recently, with the development of molecular biology and precision medicine, molec-ular diagnosis of tumor has been paid more and more attention, and may gradually become a new diagnostic standard for tumor. At present, a large number of studies have shown that long non-coding RNA (LncRNA) has significantly different expression in colorectal cancer, liver cancer, stomach cancer and other malignant tumors, and plays a regulatory role in tumor growth, prolifer-ation, invasion, migration and other processes after binding with mRNA. In addition, LncRNA com-bined with other tumor detection methods can improve its diagnosis rate. This review summarizes the differential expression of LncRNA in some tumors and the corresponding regulation of LncRNA production by binding with mRNA, and looks forward to the prospect of its clinical application.
文章引用:刘震, 朱海宏. LncRNA在部分肿瘤中的差异表达及与mRNA结合作用关系的研究现状[J]. 临床医学进展, 2023, 13(10): 16826-16832. https://doi.org/10.12677/ACM.2023.13102356

参考文献

[1] Iyer, M., Niknafs, Y., Malik, R. et al. (2015) The Landscape of Long Noncoding RNAs in the Human Transcriptome. Nature Genetics, 47, 199-208. [Google Scholar] [CrossRef] [PubMed]
[2] Cabili, M.N., Trapnell, C., Goff, L., Koziol, M., Tazon-Vega, B., Regev, A. and Rinn, J.L. (2011) Integrative Annotation of Human Large Intergenic Noncoding RNAs Reveals Global Properties and Specific Subclasses. Genes & Development, 25, 1915-1927.
[3] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Es-timates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[4] Zhou, D., He, S., Zhang, D., Lv, Z., Yu, J., Li, Q., Li, M., Guo, W. and Qi, F. (2021) LINC00857 Promotes Colorectal Cancer Progression by Sponging miR-150-5p and Upregulating HMGB3 (High Mobility Group Box 3) Expression. Bioengineered, 12, 12107-12122. [Google Scholar] [CrossRef] [PubMed]
[5] Tsai, K.W., Lo, Y.H., Liu, H., Yeh, C.Y., Chen, Y.Z., Hsu, C.W., Chen, W.S. and Wang, J.H. (2018) Linc00659, a Long Noncoding RNA, Acts as Novel Oncogene in Regulating Cancer Cell Growth in Colorectal Cancer. Molecular Cancer, 17, Article No. 72. [Google Scholar] [CrossRef] [PubMed]
[6] Ansari, H., Shahrisa, A., Birgani, Y.T., Birgani, M.T., Hajjari, M. and Asl, J.M. (2019) Long Noncoding RNAs in Colorectal Adenocarcinoma; an in silico Analysis. Pathology & Oncol-ogy Research, 25, 1387-1394. [Google Scholar] [CrossRef] [PubMed]
[7] Shao, Q., Xu, J., Deng, R., Wei, W., Zhou, B., Yue, C., Zhu, M. and Zhu, H. (2019) SNHG 6 Promotes the Progression of Colon and Rectal Adenocarcinoma via miR-101-3p and Wnt/β-Catenin Signaling Pathway. BMC Gastroenterology, 19, Article No. 163. [Google Scholar] [CrossRef] [PubMed]
[8] Gao, M., Guo, Y., Xiao, Y. and Shang, X. (2021) Comprehensive Analyses of Correlation and Survival Reveal Informative lncRNA Prognostic Signatures in Colon Cancer. World Journal of Surgical Oncology, 19, Article No. 104. [Google Scholar] [CrossRef] [PubMed]
[9] He, M., Lin, Y. and Xu, Y. (2019) Identification of Prognostic Biomarkers in Colorectal Cancer Using a Long Non- Coding RNA-Mediated Competitive Endogenous RNA Network. Oncology Letters, 17, 2687-2694. [Google Scholar] [CrossRef] [PubMed]
[10] Huang, Z., Zhou, J.K., Peng, Y., He, W. and Huang, C. (2020) The Role of Long Noncoding RNAs in Hepatocellular Carcinoma. Molecular Cancer, 19, Article No. 77. [Google Scholar] [CrossRef] [PubMed]
[11] Clavien, P.A., Lesurtel, M., Bossuyt, P.M., Gores, G.J., Langer, B. and Perrier, A. (2012) Recommendations for Liver Transplantation for Hepatocellular Carcinoma: An International Consensus Conference Report. The Lancet Oncology, 13, e11-e22. [Google Scholar] [CrossRef
[12] Zhang, Y. and Zhou, H. (2020) LncRNA BCAR4 Promotes Liver Cancer Progression by Upregulating ANAPC11 Expression through Sponging miR-1261. International Journal of Molecular Medicine, 46, 159-166. [Google Scholar] [CrossRef] [PubMed]
[13] Wu, C., Tang, Z.Y., Chen, H.Y., Zhang, J. and Zhao, C. (2019) High-Expression of lncRNA CEBPA-AS1 Promotes Liver Cancer Progression. European Review for Medical and Pharmacological Sciences, 23, 8295-8302.
[14] Kou, J.T., Ma, J., Zhu, J.Q., Xu, W.L., Liu, Z., Zhang, X.X, Xu, J.M., Li, H., Li, X.L. and He, Q. (2020) LncRNA NEAT1 Regulates Proliferation, Apoptosis and Invasion of Liver Cancer. European Review for Medical and Pharmacological Sciences, 24, 4152-4160.
[15] Zhang, Z., Wang, S., Liu, Y., Meng, Z. and Chen, F. (2019) Low lncRNA ZNF385D-AS2 Expression and Its Prognostic Significance in Liver Cancer. On-cology Reports, 42, 1110-1124. [Google Scholar] [CrossRef] [PubMed]
[16] Yan, D., Jin, F. and Lin, Y. (2020) lncRNA HAND2-AS1 Inhibits Liver Cancer Cell Proliferation and Migration by Upregulating SOCS5 to Inactivate the JAK-STAT Pathway. Cancer Biotherapy and Radiopharmaceuticals, 35, 143-152. [Google Scholar] [CrossRef] [PubMed]
[17] Zhang, Z., Wang, S., Yang, F., Meng, Z. and Liu, Y. (2020) LncRNA ROR1-AS1 High Expression and Its Prognostic Significance in Liver Cancer. Oncology Reports, 43, 55-74. [Google Scholar] [CrossRef] [PubMed]
[18] Jiao, Y., Li, Y., Jia, B., Chen, Q., Pan, G., Hua, F. and Liu, Y. (2020) The Prognostic Value of lncRNA SNHG4 and Its Potential Mechanism in Liver Cancer. Bioscience Reports, 40, BSR20190729. [Google Scholar] [CrossRef
[19] Zhuang, H., Cao, G., Kou, C. and Li, D. (2019) Over-expressed lncRNA CDKN2B-AS1 Is an Independent Prognostic Factor for Liver Cancer and Promotes Its Proliferation. Journal of Balkan Union of Oncology, 24, 1441-1448.
[20] Nong, S., Chen, X., Wang, Z., Xu, G., Wei, W., Peng, B., Zhou, L., Wei, L., Zhao, J., Wei, Q., Deng, Y. and Meng, L. (2021) Potential lncRNA Biomarkers for HBV-Related Hepatocellular Carcinoma Diagnosis Revealed by Analysis on Coexpression Network. BioMed Research International, 2021, Article ID: 9972011. [Google Scholar] [CrossRef] [PubMed]
[21] Hu, B., Ma, X., Fu, P., Sun, Q., Tang, W., Sun, H., Yang, Z., Yu, M., Zhou, J., Fan, J. and Xu, Y. (2021) The mRNA- miRNA-lncRNA Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma. Genomics Proteomics Bioinformatics, 19, 913-925. [Google Scholar] [CrossRef] [PubMed]
[22] Siegel, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. [Google Scholar] [CrossRef] [PubMed]
[23] Yusefi, A.R., Bagheri Lankarani, K., Bastani, P., Radinmanesh, M. and Kavosi, Z. (2018) Risk Factors for Gastric Cancer: A Systematic Review. Asian Pacific Journal of Cancer Prevention, 19, 591-603.
[24] Gao, J.P., Xu, W., Liu, W.T., Yan, M. and Zhu, Z.G. (2018) Tumor Heterogeneity of Gastric Cancer: From the Perspective of Tumor-Initiating Cell. World Journal of Gastroenterology, 24, 2567-2581. [Google Scholar] [CrossRef] [PubMed]
[25] Digklia, A. and Wagner, A.D. (2016) Advanced Gastric Cancer: Current Treatment Landscape and Future Perspectives. World Journal of Gastroenterology, 22, 2403-2414. [Google Scholar] [CrossRef] [PubMed]
[26] Chang, A.Y., Foo, K.F., Koo, W.H., Ong, S., So, J., Tan, D. and Lim, K.H. (2016) Phase II Study of Neo-Adjuvant Chemotherapy for Locally Advanced Gastric Cancer. BMJ Open Gastroenterology, 3, e000095. [Google Scholar] [CrossRef] [PubMed]
[27] Lv, X., Zhang, L., Huang, R. and Song, W. (2015) A Clinical Exploration of neoadjuvant Chemotherapy with Tegafur, Gimeracil, and Oteracil Potassium Capsules Combined with Oxaliplatin for Advanced Gastric Cancer. International Journal of Clinical and Experimental Medicine, 8, 19030-19036.
[28] Huang, Y., Zhang, J., Hou, L., Wang, G., Liu, H., Zhang, R., Chen, X. and Zhu, J. (2017) LncRNA AK023391 Promotes Tumorigenesis and Invasion of Gastric Cancer through Activation of the PI3K/Akt Signaling Pathway. Journal of Experimental & Clinical Cancer Research, 36, Article No. 194. [Google Scholar] [CrossRef] [PubMed]
[29] Lu, Q., Yu, T., Ou, X., Cao, D., Xie, T. and Chen, X. (2017) Po-tential lncRNA Diagnostic Biomarkers for Early Gastric Cancer. Molecular Medicine Reports, 16, 9545-9552. [Google Scholar] [CrossRef] [PubMed]
[30] Wang, S., Li, X.C., Zhu, J.R., Ma, Z.J., Ran, J.T. and Zhou, Y.N. (2021) Construction of a Novel ceRNA Network and Identification of lncRNA ADAMTS9-AS2 and PVT1 as Hub Regulators of miRNA and Coding Gene Expression in Gastric Cancer. Translational Cancer Research, 10, 938-952. [Google Scholar] [CrossRef] [PubMed]
[31] Gu, H., Zhong, Y., Liu, J., Shen, Q., Wei, R., Zhu, H., Zhang, X., Xia, X., Yao, M. and Ni, M. (2022) The Role of miR-4256/HOXC8 Signaling Axis in the Gastric Cancer Progression: Evi-dence From lncRNA-miRNA-mRNA Network Analysis. Frontiers in Oncology, 11, Article ID: 793678. [Google Scholar] [CrossRef] [PubMed]
[32] Peng, J., Zhu, Y., Dong, X., Mao, X., Lou, Y., Mu, Y., Xue, D. and Zhou, H. (2019) Construction and Analysis of lncRNA-Associated ceRNA Network Identified Potential Prognostic Biomarker in Gastric Cancer. Translational Cancer Research, 8, 1116-1128. [Google Scholar] [CrossRef] [PubMed]